Markets
Why To Keep Buying Editas Medicine Inc. (NASDAQ:EDIT) while S&P500 loss -0.56%
Editas Medicine Inc. (NASDAQ:EDIT) has a beta of 1.89. The stock’s Relative Strength Index (RSI) is 48.15, with weekly volatility at 6.16% and ATR at
Editas Medicine Inc. (NASDAQ:EDIT) has a beta of 1.89. The stock’s Relative Strength Index (RSI) is 48.15, with weekly volatility at 6.16% and ATR at
Editas Medicine Inc. (NASDAQ:EDIT) Relative Strength Index (RSI) is 54.60, with weekly volatility at 6.20% and ATR at 2.18. The EDIT stock’s 52-week price range
Editas Medicine Inc. (NASDAQ:EDIT) Relative Strength Index (RSI) is 50.38, with weekly volatility at 5.44% and ATR at 2.07. The EDIT stock’s 52-week price range
Editas Medicine Inc. (NASDAQ:EDIT) has a beta of 1.93. The stock’s Relative Strength Index (RSI) is 47.96, with weekly volatility at 5.34% and ATR at
Editas Medicine Inc. (NASDAQ:EDIT) has a beta of 1.93. The stock’s Relative Strength Index (RSI) is 47.96, with weekly volatility at 5.34% and ATR at
Editas Medicine Inc. (NASDAQ:EDIT) has a beta of 1.93. The stock’s Relative Strength Index (RSI) is 47.96, with weekly volatility at 5.34% and ATR at
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne